The traditional assessment of prognosis for patients with breast cancer is whether the axillary lymph nodes are involved. with malignant cells at the time of surgery. Node positive patients have a poor prognosis when compared to node negative patients. However. patients with node negative breast cancer do not all remain free of disease at 10 vears and up to 30% will get recurrence. Recent research has concentrated on identifying patients within this group who are at risk of recurrence and may therefore benefit from adjuvant therapy (Glick. 1988) . Patients proven to have a good prognosis may then be spared the adjuvant treatment which has recently been suggested for all patients with breast cancer irrespective of node status (Clinical Alert. NIH 1988) . Abnormal DNA content in several human tumours is an important marker for biological activity and prognosis: its role as a predictor of clinical outcome in women with primary breast cancer has been evaluated in many studies (Del Bino et al., 1989; Kallioniemi et al., 1988 : Cornelisse et al.. 1987 . Few have focused on node negative disease and the results of these are conflicting (Clark et al.. 1989 : Muss et al.. 1989 : Yuan et al.. 1991 . To assess the correlation between tumour DNA content and clinical outcome with long term follow-up, fixed archival materials are generally used for flow cytometry. Unfortunately, with fixed tissue no external standard can be used for DNA measurement (unlike fresh tissue), and the criterion for classifying the DNA histogram into diploid or aneuploid varies from one study to another. More recently, some reports have suggested that cell image analysis could provide more objective information than flow cytometnrc analysis of DNA ploidy (Bauer et al, 1990; McFadden et al. 1990 ). However, a companrson between the two methods in relation to disease prognosis has not been performed. (Elston. 1987 line of an argon laser run at 400 mW was used for fluorscence excitation. A 585 ± 42 nm band-pass filter and a linear amplifier were used to detect propidium iodide fluorescence. Ten thousand events for each sample were stored and analysed with Consort 30 software. Fresh human lymphocytes and fixed benign breast tissue sections were used as controls to standardise the fluorescence intensity scale. As the staining intensity of fixed nuclei varied from one sample to another. no external standard was included. The peak with lowest fluorescence intensity in the DNA histogram was regarded as representing the diploid cells. In most of the samples. fibroblasts. lymphocytes, and normal epithelial cells are included in this peak and can be regarded as an internal standard. Samples were classified as DNA-aneuploid if they contained more than one peak (any second peak at or near the tetraploid position was considered to indicate DNA aneuploidy only if it contained more than 10% of the total number of nuclei). All other samples were classified as diploid. Samples with a CV of the diploid peak > 10% were considered uninterpretable and excluded. DNA histograms were analysed without any information of patient clinical variables and follow-up.
to different cell populations for further processing analysis.
The IND of tumour cells in a sample were grouped according to whether they clustered around the modal value (>0.5 and < 1.5 times the tumour cell modal IND) or whether their IND was > 1.8 times the modal value. A tumour was considered aneuploid by image analysis if the geometric mean of the cells clustered around the modal value was > 1.5 times that of the lymphocytes in the same sample: or if the tumour cells with high IND were more than 10% of the total number of tumour cells measured. This method of classification was felt to parallel the classification system used for the flow cytometry results (Figures 1 and 2 Table II ). There were 20 tumours with discrepancies between the two methods. 18 of these were tumours with only one peak in flow analysis but determined to be aneuploid with image analysis. DNA content as measured by both methods was significantly associated with histological grade (P<0.01), but was not significantly related to menopausal status or tumour size (Table III) . C-erbB-2 expression was significantly related to DNA ploidy by flow cytometry (P<0.01). but not by cell image analysis (P = 0.13). Compared to those with diploid tumours, patients with aneuploid tumours had significantly earlier relapse and shorter survival after a minimum of 10 years follow-up, as determined by log-rank test (Figures 3 and 4) . Histological grade, c-erbB-2 expression and tumour size were also related to relapse and survival (Table IV) . Multivariate analysis showed DNA ploidv measured by flow cytometry to be the only variable of independent significance (P <0.02) for both relapse and overall survival in the patients with node negative disease. Ploidy measured by image analysis, tumour grade. c-erbB-2 expression and tumour size were not of independent significance (Table IV) . Table V indicates the increased sensitivity. but loss of specificity. in correlation with survival that is found when image analysis is used instead of flow cytometry for determination of tumour ploidy. In detecting overall survival after 10 years flow cytometry showed a sensitivity of 74.5% compared with that of image analysis (83%). However. flow cytometry showed better specificity (63%) than image analysis (40.70o). The prognostic significance of DNA content in patients with node negative breast cancer has been studied using flow cvtometry. but the results have not been uniform (Clark et al.. 1989 : Muss et al.. 1989 : Yuan et al.. 1991 . In the present (35) 28 (18) T.
26 (32) 17 (11) study the DNA content of tumours from 101 breast cancer patients with node negative disease was determined by flow cytometry and cell image analysis. In keeping with other reports. we found that the flow cytometric analysis demonstrated a higher proportion of diploid tumours (46%) than that obtained by image analysis (30%). Of the discrepancies. 90% (18 samples) were tumours classified as diploid by flow cytometry but considered as aneuploid by image analysis. Because flow cytometry assays the relative number of cells in different populations. the resolution of normal diploid from abnormal aneuploid populations by flow cytometric analysis depends not only on the amount of overlap of the two distributions but also on the clear presence of a significant proportion of both normal and abnormal cells. There are therefore three possible explanations for flow cytometry failing to detect an aneuploid population: (a) a wide coefficient of variation of the diploid peak in flow cytometry might mask an aneuploid population (cf. McFadden et al.. 1990 ): (b) the aneuploid population might be low in proportion to the number of normal cells and or at the tetraploid position and therefore could be missed or misinterpreted as an increased G, + M peak by flow cytometry (Bauer et al.. 1990 ): or (c) if normal cells are low in proportion to the number of tumour cells and therefore do not form an indentifiable peak in the flow histogram. the aneuploid population might be misinterpreted as normal. It is worth mentioning that in McFadden's study (1990 tumour cells and on normal ly-mphocytes from slides of the paraffin sections: as long as both types of cells were present. classification by image analysis was therefore not affected by the relative proportions of the two types of cells. Our results suggest that image analysis techniques can provide more objective information of the DNA content of tumour cells by direct measurement of integrated nuclear DNA density on selected cells and by using normal lymphocytes in the same section as controls. Image analysis, in particular. allows measurements of samples with either few lymphocytes or few tumour cells. The disadvantage of image analysis is that the operator must be familiar with cell morphology and also that the results may be affected by the selection of nuclei for measurement and by the criteria adopted to classify samples as diploid or aneuploid. In the present study. we used the ratio 1.5 as a cutoff point based on the results comparing normal breast ductal cells to normal lymphocytes. DNA ploidy measured by both methods was significantly associated with histological grade. which in itself was a good predictor of clinical outcome on univariate analysis. DNA aneuploidy was strongly associated with poorly differentiated tumours. which is in agreement with other studies (Feichter et al., 1988; Kallioniemi et al.. 1987 : O'Reilly et al.. 1990 ). There was positive correlation between nuclear size and IND: since nuclear size is an important parameter in histological grading. the relationship between DNA ploidy and histological grade is to be expected. Although the DNA ploidy results measured by the two methods were significantly different. the outcome for patients in this study was significantly related to tumour ploidy as determined by either method. Patients with aneuploid tumours by both methods had shorter disease free and overall survival by univariate analysis after a minimum 10 years follow-up. To examine the relative importance of DNA ploidy as a prognostic factor in patients with node negative breast cancer. the independent prognostic significance of these results must be assessed by multivariate analysis. DNA ploidy measured by flow cytometry was of independent value when related to prognosis. but DNA content measured by image analysis was not. Therefore. the increased sensitiVity of image analysis for detecting aneuploid cells was not reflected in increased clinical value.
With the advent of the National Breast Screening Programme the number of women presenting with node negative breast cancer will increase, and identification of women with potentially poor outcome from within such good prognostic groups is difficult. Tumour ploidy. measured by either flow cytometry or image analysis. may play an important role in this task.
